Highly effective new anti-cancer drug
Professor Yusuke Nakamura
OncoTherapy Science (OTS) was founded to pursue “To develop anti-cancer medicine and anti-cancer therapy with high efficacy and minimum risk of adverse events, and to win the war against cancer”. By collaborating with Professor Yusuke Nakamura (Director of Cancer Precision Medicine Center of JAPANESE FOUNDATION FOR CANCER RESEARCH, Emeritus Faculty Professor of University of Chicago, and Professor Emeritus of University of Tokyo) who is one of the pioneers of applying genomics to the medical field, OTS identified target molecules applicable to anti-cancer medicine development, and has been pursuing research and development for small molecule medicine, cancer peptide vaccine and antibody medicine for the target molecules.